Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn’s colitis

We report a case of intestinal indolent T-cell lymphoproliferative disease (TCLPD) occurring after the initiation of tumor necrosis factor‒α (TNF-α) inhibitor therapy for resistant Crohn’s disease. A prominent T-cell infiltrate positive for CD8, TIA-1, and T-cell receptor–βF1 was associated with the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Hum Pathol
Huvudupphovsmän: Edison, Natalia, Belhanes-Peled, Hila, Eitan, Yuval, Guthmann, Yifat, Yeremenko, Yelena, Raffeld, Mark, Elmalah, Irit, Trougouboff, Philippe
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830738/
https://ncbi.nlm.nih.gov/pubmed/27402301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2016.06.021
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk